NDC 62756-974

INFUGEM

Gemcitabine

INFUGEM is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Gemcitabine Hydrochloride.

Product ID62756-974_6fc95d4c-11c7-4877-b9fe-be5521bae272
NDC62756-974
Product TypeHuman Prescription Drug
Proprietary NameINFUGEM
Generic NameGemcitabine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-10-01
Marketing CategoryNDA / NDA
Application NumberNDA208313
Labeler NameSun Pharmaceutical Industries, Inc.
Substance NameGEMCITABINE HYDROCHLORIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62756-974-60

1 POUCH in 1 CARTON (62756-974-60) > 1 BAG in 1 POUCH > 220 mL in 1 BAG
Marketing Start Date2018-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62756-974-60 [62756097460]

INFUGEM INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA208313
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-10-01

Drug Details

Active Ingredients

IngredientStrength
GEMCITABINE HYDROCHLORIDE10 mg/mL

OpenFDA Data

SPL SET ID:4e7e5088-d476-40e2-8cbd-dfeed4ddd166
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2058893
  • 2058890
  • 2058858
  • 2058927
  • 2058928
  • 2058933
  • 2058866
  • 2058867
  • 2058934
  • 2058912
  • 2058863
  • 2058918
  • 2058892
  • 2058880
  • 2058881
  • 2058882
  • 2058883
  • 2058891
  • 2058895
  • 2058894
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "INFUGEM" or generic name "Gemcitabine"

    NDCBrand NameGeneric Name
    62756-614INFUGEMINFUGEM
    62756-073INFUGEMINFUGEM
    62756-219INFUGEMINFUGEM
    62756-746INFUGEMINFUGEM
    62756-974INFUGEMINFUGEM
    62756-438INFUGEMINFUGEM
    62756-533INFUGEMINFUGEM
    62756-321INFUGEMINFUGEM
    62756-008INFUGEMINFUGEM
    62756-102INFUGEMINFUGEM
    0143-9394GemcitabineGemcitabine
    0143-9395GemcitabineGemcitabine
    0409-0181GemcitabineGEMCITABINE
    0409-0182GemcitabineGEMCITABINE
    0409-0183GemcitabineGEMCITABINE
    0409-0185GemcitabineGEMCITABINE
    0409-0186GemcitabineGEMCITABINE
    0409-0187GEMCITABINEGEMCITABINE
    16729-391GEMCITABINEGEMCITABINE
    16729-419GEMCITABINEGEMCITABINE
    16729-423GEMCITABINEGEMCITABINE
    16729-426GEMCITABINEGEMCITABINE

    Trademark Results [INFUGEM]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    INFUGEM
    INFUGEM
    88173516 not registered Live/Pending
    Sun Pharmaceutical Industries Limited
    2018-10-29
    INFUGEM
    INFUGEM
    87478635 not registered Dead/Abandoned
    Sun Pharmaceutical Industries Limited
    2017-06-07
    INFUGEM
    INFUGEM
    87097112 5940989 Live/Registered
    Sun Pharmaceutical Industries Limited
    2016-07-08
    INFUGEM
    INFUGEM
    87097079 not registered Live/Pending
    Sun Pharmaceutical Industries Limited
    2016-07-08

    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.